Shorters pushing it down
Large short volume has started since the spike last week .
Company is developing potential new drugs in Cancer , Dermatology , Neurology and even obesity
Morningstar fair value is 2.55
several analysts' fair value is above 4.00
number of shares around 5 mil so with current price the market cap is only 3mil !!! Totally unfair and undervalued
Other small caps pharma companies with less potential are trading with much higher price in Nasdaq
The company needs to release more data and boost the stock to its fair value
all those 10k blocks selling at 70 cents and low prices are vile shorters . such a shame
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
